Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick J Leavey

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Pediatric Blood & Cancer|November 16, 2012
How many physicians do we need? A benchmark for pediatric hematology/oncologyPatrick J Leavey
Pediatric Blood & Cancer|October 21, 2014
Important principles in Ewing sarcoma treatmentPatrick J Leavey
Pediatric Blood & Cancer|June 29, 2016
Biomarker development in osteosarcoma-Is there no longer any utility to tumor necrosis?Patrick J Leavey
Expert Review of Anticancer Therapy|April 12, 2008
Ewing sarcoma: prognostic criteria, outcomes and future treatmentPatrick J Leavey, Anderson B Collier
Pediatric Blood & Cancer|April 11, 2012
Graduate medical education changes: yes we can or enough already?Patrick J Leavey, Rima F Jubran
Pediatric Hematology and Oncology|September 10, 2002
Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcomaPatrick J Leavey, Elpis Mantadakis, Gerhard Maale
Journal of Pediatric Hematology/Oncology|October 7, 2003
Skip metastasis in osteosarcomaPatrick J Leavey, Michael D Day, Timothy Booth, et al.
Medical and Pediatric Oncology|April 30, 2002
Brief report: successful therapy of a patient with infantile generalized myofibromatosisMichael Day, Albert O Edwards, Arthur Weinberg, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 2, 2006
KAI-1 expression in pediatric high-grade osteosarcomaPatrick J Leavey, Charles Timmons, William Frawley, et al.
Journal of Pediatric Hematology/Oncology|June 20, 2014
Bone scintigraphy in osteosarcoma: a single institution experienceJacquelyn M Powers, Carrye Cost, Kevin Cederberg, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Pediatric Blood & Cancer|November 16, 2012
How many physicians do we need? A benchmark for pediatric hematology/oncologyPatrick J Leavey
Pediatric Blood & Cancer|October 21, 2014
Important principles in Ewing sarcoma treatmentPatrick J Leavey
Pediatric Blood & Cancer|June 29, 2016
Biomarker development in osteosarcoma-Is there no longer any utility to tumor necrosis?Patrick J Leavey
Expert Review of Anticancer Therapy|April 12, 2008
Ewing sarcoma: prognostic criteria, outcomes and future treatmentPatrick J Leavey, Anderson B Collier
Pediatric Blood & Cancer|April 11, 2012
Graduate medical education changes: yes we can or enough already?Patrick J Leavey, Rima F Jubran
Pediatric Hematology and Oncology|September 10, 2002
Variability in dose intensity of high-dose methotrexate for nonmetastatic osteosarcomaPatrick J Leavey, Elpis Mantadakis, Gerhard Maale
Journal of Pediatric Hematology/Oncology|October 7, 2003
Skip metastasis in osteosarcomaPatrick J Leavey, Michael D Day, Timothy Booth, et al.
Medical and Pediatric Oncology|April 30, 2002
Brief report: successful therapy of a patient with infantile generalized myofibromatosisMichael Day, Albert O Edwards, Arthur Weinberg, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 2, 2006
KAI-1 expression in pediatric high-grade osteosarcomaPatrick J Leavey, Charles Timmons, William Frawley, et al.
Journal of Pediatric Hematology/Oncology|June 20, 2014
Bone scintigraphy in osteosarcoma: a single institution experienceJacquelyn M Powers, Carrye Cost, Kevin Cederberg, et al.
Pageof 5